Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population

International Journal of Artificial Organs

Volumn 30, Issue 1, 2007, Pages 6-15

  Fabrizi, Fabrizio ^a   de Vecchi, A F ^a   Qureshi, A R ^b   Aucella, F ^c   Lunghi, G ^a   Bruchfeld, A ^b   Bisegna, S ^d   Mangano, S ^e   Limido, A ^f   Vigilante, D ^g   Forcella, M ^h   delli Carri, P ⁱ   Martin, P ^j  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Department of Radiology   (Italy)

^d Melegnano Hospital   (Italy)

^e Sant'Anna Como Hospital   (Italy)

^f Nephrology Unit   (Italy)

^g Via San Camillo de Lellis   (Italy)

^h UOC San Severo Hospital   (Italy)

ⁱ University Hospital of Foggia   (Italy)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Dialysis; Gamma glutamyltranspeptidase; Hepatitis B virus; Hepatitis C virus

Indexed keywords

BODY FLUIDS; MULTIVARIANT ANALYSIS; NUCLEIC ACIDS; REGRESSION ANALYSIS; VIRUSES;

AMINOTRANSFERASE; CLINICAL PARAMETERS; DEMOGRAPHIC PARAMETERS; GAMMA GLUTAMYLTRANSPEPTIDASE; HEALTHY CONTROLS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOCELLULAR; MULTI VARIATE ANALYSIS; VIRAL HEPATITIS;

DIALYSIS;

GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CHOLELITHIASIS; COHORT ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GALLBLADDER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HEPATOBILIARY SYSTEM; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; RECEIVER OPERATING CHARACTERISTIC; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

EID: 34147107054     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000103     Document Type: Article

References (48)

1. Finelli L, Miller JT, Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61.
2. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003; 63: 2222-9.
3. Vladutiu D, Cosa A, Neamtu A, State D, Braila M, Gherman M, Patiu IM, Dulau-Florea. Infection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat 2000; 7: 313-9.
4. Cendoroglo Neto N, Rodrigues Manzano SI, Canziani ME, Silva AEB, Cirenza MLF, de Cintra Sesso R, Ajzen H, Draibe SA. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. lnt J Artif Organs 1995; 19: 251-5.
5. Covic A, Iancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999; 14: 40-5.
6. Lewis-Ximenez LL, Oliveira JM, Mercadante LAC, De Castro L, Santa Catharina W, Stuver S, Yoshida CFT. Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 2001; 87: 19-26.
7. Jankovic N, Cala S, Nadinic B, Varlai-Knobloch V, Pavlovic D. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up. Int J Artif Organs 1994; 17: 137-40.
8. Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients. California, Nebraska, and Texas, 1994. JAMA 1996; 275: 1394-5.
9. Hutin YJF, Goldstein ST, Varma JK, O'Dair JB, Mast EE, Shapiro CN, Alter MJ. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999; 20: 731-5.
10. Tanaka S, Yoshiba M, Iino S, Fukuda M, Nakao H, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutants. Kidney Int 1995; 48: 1972-8.
11. Roll M, Norder H, Magnius O, Grillner L, Lindgren V. Nosocomial spread of hepatitis B virus (HBV) in a haemodialysis unit confirmed by HBV DNA sequencing. J Hosp Infect 1995; 30: 57-63.
12. Igaki N, Nakaji M, Moriguchi R, Akiyama H, Tamada F, Oimomi MT. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients. J Gastroenterol 2003; 38: 968-76.
13. Salama G, Rostaing L, Sandres K, Izopet J. Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol 2000; 61: 44-51.
14. Lombardi M, Cerrai T, Geatti S, Negroni S, Pertusini L, Pegoraro M, Di Lullo G. Results of a national epidemiological investigation on HCV infection among dialysis patients. J Nephrol 1999; 12: 322-7.
15. Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk H, van Loon AM, van Dijk WC, Kauffmann RH, Quint W, van Doorn LJ. Hepatitis C virus infections in dialysis centers in the Netherlands: a national survey by serological and molecular methods. J Clin Microbiol 1998; 36: 1711-5.
16. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 2001; 38: 1009-15.
17. Fabrizi F, Lunghi G, Andrulli S, Faranna P, Pagliari B, Mangano S, Pagano A, Locatelli F. Influence of hepatitis C viremia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394-8.
18. Fabrizi F, Mangano S, Alongi G, Bisegna S, Finazzi S, Lunghi G, Ponticelli C. Influence of hepatitis B virus viremia upon serum aminotransferase activity in dialysis population. Int J Artif Organs 2003; 26: 1048-55.
19. Mondelli MU, Smedile V, Piazza V, Villa G, Barbieri C, Gattarello G, Mancini F, Raimondo G. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in hemodialysis patients. Nephrol Dial Transplant 1991; 6: 480-3.
20. Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K. Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1353-6.
21. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron 1998; 80: 428-34.
22. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69: 459-65.
23. Simon N, Couroucè AM, Lemarrec N, Trepo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504-11.
24. Poux JM, Cadranel JF, Fievet P, Dumouchel P, Collot G. Measurement of gamma glutamyl transpeptidase activity: a useful and low-cost tool for the detection of HCV infection in haemodialysed patients (letter). Nephrol Dial Transplant 1998; 13: 1324.
25. Martin P, Friedman LS. Assessment of liver function and diagnostic studies. In: Friedman LS, Keeffe EB (eds). Handbook of liver disease. Philadelphia, PA: Elsevier Science; 2004. p 1-16.
26. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC, Balart LA, Ortego TJ, Payne J, Dienstag JL, Gibas A, Jacobson IM, Tamburro CH, Carey W, O'Brien C, Sampliner R, Van Thiel DH, Feit D, Albrecht J, Meschievitz C, Sanghvi B, Vaughan RD, Hepatitis Interventional Therapy Group. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595-603.
27. Giannini E, Botta F, Fasoli A, Romagnoli P, Mastracci L, Ceppa P, Comino I, Pasini A, Risso D, Testa R. Increased levels of GT suggest the presence of bile duct lesions in patients with chronic hepatitis C. Dig Dis Sci 2001; 46: 524-9.
28. Mazzella G, Salzetta A, Casanova S, Morelli MC, Villanova N, Miniero R, Sottili S, Novelli V, Cipolla A, Festi D, Roda E. Treatment of chronic sporadic-type non-A, non-B hepatitis B with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci 1994; 39: 866-70.
29. Zweig MH, Campbell G. Receiver-operating characteristics (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
30. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, Sansonetti N, Opolon P. Factors associated with serum alanine aminotransferase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology 1998; 27: 1213-9.
31. Kiyosawa K. Non-alcoholic steatohepatitis and GB virus-C/hepatitis G virus infection: is there a causal relationship? Intern Med 1997; 36: 236-7.
32. Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Hebisawa A. Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease. Hepatol Res 2001; 19: 197-211.
33. Conte D, Barisani D, Mandelli C, Bodini P, Borzio M, Pistoso S, Sega M, Aimo GP, Fraquelli M, Bianchi PA. Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol 1991; 86: 1629-32.
34. Sheen IS, Liaw YF. The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: A prospective study. Hepatology 1989; 9: 538-40.
35. Badalamenti S, De Fazio C, Castelnovo C, Sangiovanni A, Como G, De Vecchi A, Graziani G, Colombo M, Ponticelli C. High prevalence of silent gallstone disease in dialysis patients. Nephron 1994; 66: 225-7.
36. Li Vecchi M, Cesare S, Soresi M, Arnone S, Renda F, Di Natale E, Figliola C, Li Vecchi V, Carroccio A, Montalto G. Prevalence of biliary lithiasis in a Sicilian population of hemodialysis patients. Clin Nephrol 2001; 55: 127-32.
37. Tzanakis I, Papadaki A, Kagia S, Karefyllakis N, Spandidakis V, Girousis N, Kallivretakis N. Prevalence of cholelithiasis in hemodialysis patients (letter). Clin Nephrol 2003; 59: 483-4.
38. Hung KY, Lee KG, Yen CJ, Wu KD, Tsai TJ, Chen WY. Revised cut-off values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 180-3.
39. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology 1995; 109: 1295-300.
40. Crawford DR, Reyna RS, Weiner MW. Effects of in vivo and in vitro dialysis on plasma transaminase activity. Nephron 1978; 22: 418-22.
41. Chimata M, Masaoka H, Fujmaki M, Hamada N, Oda K, Sudo M, Nagase M. Low serum aminotransferase activity in patients undergoing regular hemodialysis. Nippon Jinzo Gakkai Shi 1994; 36: 389-95.
42. Cohen GA, Goffinet JA, Donabedian RK, Conn HO. Observations on decreased serum glutamic oxaloacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1976; 84: 275-80.
43. Wolf PL, Williams D, Coplon N, Coulson AS. Low aspartate aminotransferase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 1972; 18: 567-8.
44. Warnock LG, Stone WJ, Wagner C. Decreased aspartate aminotransferase ("SGOT") activity in serum of uremic patients. Clin Chem 1974; 20: 1213-6.
45. Ross EA, Shah GM, Reynolds RD, Sabo A, Pichon M. Vitamin B6 requirements of patients on chronic peritoneal dialysis. Kidney Int 1989; 36: 702-6.
46. Espinosa M, Martin-Malo A, Alvarez-de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-6.
47. Neff GW, O'Brien C, Montalbano M, DeManno A, Kahn S, Safdar K, Nishida S, Tzakis A. Consumption of dietary supplements in a liver transplant population. Liver Transplant 2004; 10: 881-5.
48. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50 (RR-5): 1-43.